Biogen 2024年第四季度调整后每股收益为$3.44，超出预期的$3.35；销售额为$24.6亿，超出预期的$24亿

财报速递2025-02-12
Biogen（NASDAQ:BIIB）报告其季度每股收益为$3.44，这一数字比分析师一致预期的$3.35高出2.69%。较去年同期每股收益$2.95增长了16.61%。公司报告季度销售额为$24.6亿，超出分析师一致预期的$24亿2.17%。较去年同期销售额$23.9亿增长了2.89%。

以上内容来自Benzinga Earnings专栏，原文如下：

Biogen (NASDAQ:BIIB) reported quarterly earnings of $3.44 per share which beat the analyst consensus estimate of $3.35 by 2.69 percent. This is a 16.61 percent increase over earnings of $2.95 per share from the same period last year. The company reported quarterly sales of $2.46 billion which beat the analyst consensus estimate of $2.40 billion by 2.17 percent. This is a 2.89 percent increase over sales of $2.39 billion the same period last year.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法